Geetha Puthenveetil
Pediatric Hematology-Oncology · Los Angeles, CANPI 1174626683
Payments from drug & device makers
Across 126 payments — averaging $1511.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Global Blood Therapeutics, Inc.$67K
- Agios Pharmaceuticals, Inc.$39K
- AMAG Pharmaceuticals, Inc.$26K
- Novartis$15K
- Vertex$12K
- Acceleron Pharma, Inc.$9K
- plus $21K from 14 others
Across 1 payment — averaging $1750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$2K
What the payments were for
- Consulting fees$44,83872%
- Speaking & faculty fees$12,69020%
- Travel & lodging$2,7254%
- Food & beverage$1,9283%
- Education$400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Global Blood Therapeutics, Inc. | 28 | $67,388 |
| Agios Pharmaceuticals, Inc. | 15 | $38,910 |
| AMAG Pharmaceuticals, Inc. | 7 | $26,325 |
| Novartis | 12 | $15,273 |
| Vertex | 12 | $12,424 |
| Acceleron Pharma, Inc. | 3 | $9,480 |
| AstraZeneca | 23 | $9,372 |
| Chiesi USA, Inc. | 8 | $8,501 |
| Bristol Myers Squibb | 1 | $1,902 |
| Terumo BCT, Inc. | 2 | $240 |
| CSL Behring | 2 | $143 |
| Spark Therapeutics, Inc. | 2 | $123 |
| Pierre Fabre Pharmaceuticals, Inc. | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Genentech USA, Inc. | 1 | $48 |
| Amgen | 1 | $37 |
| Mesoblast, Inc. | 1 | $32 |
| Eurofins Viracor, LLC | 1 | $29 |
| Bio Products Laboratory USA, Inc. | 1 | $23 |
| Medunik USA Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Reblozyl$11,342
- OXBRYTA$10,865
- FERRIPROX$8,421
- PYRUKYND$5,507
- SOLIRIS$4,286
- ULTOMIRIS$1,252
- Spectra Optia$137
- Spectra Optia Apheresis System$103
How this compares
$190,395 in reported general payments places this provider in the 75th percentile of 307 pediatric hematology-oncology providers in California.
See all pediatric hematology-oncology providers in California →
Other pediatric hematology-oncology in Los Angeles
- Alan WayneLos Angeles$3.8M
- Fariba NavidLos Angeles$2.5M
- Araz MarachelianLos Angeles$2.1M
- Thomas CoatesLos Angeles$2.1M
- Leo MascarenhasLos Angeles$1.6M
- Robert CooperLos Angeles$1.4M
- Vivian ChangLos Angeles$1.4M
- Noah FedermanLos Angeles$1.4M
- Hisham Abdel AzimLos Angeles$1.3M
- Michael PulsipherLos Angeles$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.